{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:52:55Z","timestamp":1785876775318,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jfo.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T12:34:51Z","timestamp":1646656491000},"page":"511-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas"],"prefix":"10.1016","volume":"45","author":[{"given":"H.","family":"Hacisahinogullari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Canturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dogansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2022.01.002_bib0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.jfo.2022.01.002_bib0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia. An Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.jfo.2022.01.002_bib0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin. Endocrinol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","article-title":"Giant prolactinomas: clinical management and long-term follow up","volume":"97","author":"Shrivastava","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jfo.2022.01.002_bib0160","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","article-title":"Giant prolactinomas in men: efficacy of cabergoline treatment","volume":"58","author":"Corsello","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-14-0013","article-title":"Therapy of endocrine disease: the challenges in managing giant prolactinomas","volume":"170","author":"Maiter","year":"2014","journal-title":"Eur. J. Endocrinol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0170","first-page":"2102","article-title":"Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study","volume":"82","author":"Delgrange","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2022.01.002_bib0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1259\/bjr\/98771490","article-title":"Unusual orbital invasion by a giant prolactinoma","volume":"81","author":"Siddiqui","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0180","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/OPX.0b013e31826b094b","article-title":"Prolactinomas and the eye: a clinical case and review","volume":"89","author":"Sink","year":"2012","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jfo.2022.01.002_bib0185","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","article-title":"Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2022.01.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-016-0723-4","article-title":"Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas","author":"Shimon","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.jfo.2022.01.002_bib0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/cen.12242","article-title":"Giant prolactinomas: the therapeutic approach","volume":"79","author":"Moraes","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endoc Rev"},{"key":"10.1016\/j.jfo.2022.01.002_bib0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1026225625897","article-title":"Dopamine resistance of prolactinomas","volume":"6","author":"Molitch","year":"2003","journal-title":"Pituitary"},{"key":"10.1016\/j.jfo.2022.01.002_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01815445","article-title":"Giant pituitary adenomas","volume":"8","author":"Pia","year":"1985","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.jfo.2022.01.002_bib0215","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.surneu.2003.08.036","article-title":"Giant pituitary tumors: a study based on surgical treatment of 118 cases","volume":"61","author":"Goel","year":"2004","journal-title":"Surg Neurol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0220","first-page":"211","article-title":"Surgery combined with dopamine agonists versus dopamine agonists alonein long-term treatment of macroprolactinoma: a retrospective study Exp","volume":"106","author":"H\u00f6fle","year":"1998","journal-title":"Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jfo.2022.01.002_bib0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-005-5087-0","article-title":"Combined treatment of invasive giant prolactinomas","volume":"8","author":"Yu","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.jfo.2022.01.002_bib0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1507\/endocrj.45.529","article-title":"Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment","volume":"45","author":"Saeki","year":"1998","journal-title":"Endocr J"},{"key":"10.1016\/j.jfo.2022.01.002_bib0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-06-0646","article-title":"Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men","volume":"156","author":"Shimon","year":"2007","journal-title":"Eur J Endocrin"},{"key":"10.1016\/j.jfo.2022.01.002_bib0240","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4067\/S0034-98872013000600001","article-title":"Visual outcome in patients with macroprolactinoma treated with dopamine agonists","volume":"141","author":"Cuevas","year":"2013","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.jfo.2022.01.002_bib0245","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2008.03364.x","article-title":"Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma","volume":"70","author":"Raverot","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0250","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11102-009-0179-x","article-title":"Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma","volume":"14","author":"Dhanwal","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.jfo.2022.01.002_bib0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF03401344","article-title":"Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?","volume":"13","author":"Papanastasiou","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jfo.2022.01.002_bib0260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fendo.2017.00192","article-title":"Brain and optic chiasm herniation into sella after pituitary tumor apoplexy","volume":"8","author":"Pineyro","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0265","first-page":"60","article-title":"Delayed chiasmal herniation after transsphenoidal removal of a pituitary adenoma - case report","volume":"42","author":"Ergungor","year":"2008","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.jfo.2022.01.002_bib0270","article-title":"Endonasal chiasmapexy using autologous cartilage\/bone for empty sella syndrome after cabergoline therapy for prolactinoma: a case report","author":"Ishihara","year":"2018","journal-title":"World Neurosurg"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551222000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551222000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:17:42Z","timestamp":1759259862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551222000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0181551222000791"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2022.01.002","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}